STEPHENS INC /AR/ - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 174 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
STEPHENS INC /AR/ ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2019$240,000
+2.1%
6,178
+20.6%
0.01%0.0%
Q3 2018$235,000
-40.2%
5,121
+13.8%
0.01%
-53.8%
Q2 2017$393,000
+30.1%
4,5000.0%0.01%0.0%
Q3 2016$302,000
-14.4%
4,5000.0%0.01%
-27.8%
Q4 2015$353,000
+4.1%
4,5000.0%0.02%0.0%
Q3 2015$339,000
-35.4%
4,5000.0%0.02%
-25.0%
Q2 2015$525,000
-50.6%
4,5000.0%0.02%
-50.0%
Q1 2015$1,062,000
+24.6%
4,5000.0%0.05%
+20.0%
Q4 2014$852,000
-20.7%
4,5000.0%0.04%
-24.5%
Q3 2014$1,074,000
+261.6%
4,5000.0%0.05%
+253.3%
Q2 2014$297,000
-36.7%
4,5000.0%0.02%
-42.3%
Q1 2014$469,000
+0.6%
4,5000.0%0.03%
+13.0%
Q4 2013$466,000
+93.4%
4,5000.0%0.02%
+76.9%
Q3 2013$241,0004,5000.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2017
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 200,000$20,706,0006.01%
Redmile Group, LLC 230,673$23,882,0002.95%
WEATHERBIE CAPITAL, LLC 241,419$24,994,0002.31%
Tekla Capital Management LLC 185,820$19,238,0002.02%
Ghost Tree Capital, LLC 25,000$2,588,0001.59%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$588,741,0001.56%
Iguana Healthcare Management, LLC 25,000$2,588,0001.48%
Eventide Asset Management 42,100$4,359,0001.34%
Bain Capital Public Equity Management, LLC 401,330$41,550,0001.17%
Rock Springs Capital Management LP 31,500$3,261,0001.16%
View complete list of PUMA BIOTECHNOLOGY INC shareholders